NCT00687180

Brief Summary

A study with 20 de novo patients with autoimmune hepatitis, 10 receiving azathioprin and 10 receiving mycophenolat mofetil.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 30, 2008

Completed
Last Updated

May 30, 2008

Status Verified

May 1, 2008

First QC Date

May 28, 2008

Last Update Submit

May 29, 2008

Conditions

Autoimmune Hepatitis

Keywords

Prednisolone dosage

Study Arms (2)

I

ACTIVE COMPARATOR

MMF

Drug: Treatment with mycophenolat mofetil

II

ACTIVE COMPARATOR
Drug: Treatment with azathioprin

Interventions

Treatment with mycophenolat mofetilDRUG
I
Treatment with azathioprinDRUG
II

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • De novo autoimmune hepatitis
  • Consent

You may not qualify if:

  • age below 18
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rigshospitalet, Dept. of Hepatology A-2121

Copenhagen, 2100, Denmark

Location

MeSH Terms

Conditions

Hepatitis, Autoimmune

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Hepatitis, ChronicHepatitisLiver DiseasesDigestive System DiseasesAutoimmune DiseasesImmune System Diseases

Study Design

Study Type
interventional
Phase
phase 4
Purpose
TREATMENT
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 28, 2008

First Posted

May 30, 2008

Last Updated

May 30, 2008

Record last verified: 2008-05

Locations

DK(1)